| 标题 |
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:P. Pfeiffer; M. Yilmaz; Sören Möller; D. Zitnjak; M. Krogh; et al 出版日期:2020-01-27 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)